Pozen Inc. (POZN) President, CEO and Chairman, 10% Owner John R Plachetka sells 12,500 Shares

Author's Avatar
Sep 02, 2009
President, CEO and Chairman, 10% Owner of Pozen Inc. (POZN, Financial) John R Plachetka sells 12,500 shares of POZN on 08/31/2009 at an average price of $6.8 a share.

Pozen Inc. is pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. Its initial area of focus is migraine where the company have built a portfolio of four product candidates through a combination of innovation and in-licensing. Its lead product candidate is MT 100 which the company is developing as an oral first-line therapy for the treatment of migraine. Pozen Inc. has a market cap of $185.7 million; its shares were traded at around $6.23 with and P/S ratio of 2.8.

Recent Trades of Pozen Inc. by CEO:
  • Sell: President, CEO and Chairman, 10% Owner John R Plachetka sold 12,500 shares of POZN stock on 08/24/2009 at the average price of $6.25; the price of the stock has decreased by 0.32% since.

  • Sell: President, CEO and Chairman, 10% Owner John R Plachetka sold 12,500 more shares of POZN stock on 08/17/2009 at the average price of $6.79; the price of the stock has decreased by 8.25% since.

  • Sell: President, CEO and Chairman, 10% Owner John R Plachetka sold 12,500 more shares of POZN stock on 08/10/2009 at the average price of $7.45; the price of the stock has decreased by 16.38% since.

  • Sell: President, CEO and Chairman, 10% Owner John R Plachetka sold 12,500 more shares of POZN stock on 08/03/2009 at the average price of $7.68; the price of the stock has decreased by 18.88% since.



Recent Trades of Pozen Inc. by Directors and Officers:
  • Sell: VP, Finance and Administration John E Barnhardt sold 10,000 shares of POZN stock on 08/12/2009 at the average price of $7.54; the price of the stock has decreased by 17.37% since.

  • Sell: VP, Finance and Administration John E Barnhardt sold 10,000 more shares of POZN stock on 07/15/2009 at the average price of $7.58; the price of the stock has decreased by 17.81% since.